ALLMedicine™ Vaginal Cancer Center

Mar 2nd, 2021 - Uterine transposition has emerged as an alternative for fertility preservation in women with pelvic malignancies that require radiotherapy. The goal of this study was to evaluate the short-term outcomes of patients undergoing uterine transposition...

Jan 7th, 2021 - Women's sexual health and wellbeing with cervical or vaginal cancer may be largely affected by complications from external beam radiotherapy (EBRT) and utero-vaginal brachytherapy (BT), of which vaginal stenosis is the main complication. The objec...

Dec 4th, 2020 - Vaginal cancer is a rare disease of the lower genital tract. We present the case of a 54-year-old woman with occult vaginal cancer after hysterectomy for cervical intraepithelial neoplasia (CIN) III. Despite persistently negative cytology and colp...

Nov 9th, 2020 - The role of the prosthodontist in radiation therapy includes fabrication of radiation therapy prosthetic applicators. Brachytherapy is a form of cancer treatment that involves direct insertion of radioactive implants into the tissue. In the case o...

Nov 9th, 2020 - High dose rate (HDR) interstitial brachytherapy (ISBT) boost is integral for definitive radiation treatment of primary vaginal cancer. Technological advances with CT or MRI guidance provide improved precision and ability to treat more extensively ...

Nov 21st, 2017 - Vulvar cancer and vaginal cancer are relatively rare tumors, and there had been no established treatment principles or guidelines to treat these rare tumors in Japan. The first version of the Japan Society of Gynecologic Oncology (JSGO) guidelines...

Mar 2nd, 2021 - Uterine transposition has emerged as an alternative for fertility preservation in women with pelvic malignancies that require radiotherapy. The goal of this study was to evaluate the short-term outcomes of patients undergoing uterine transposition...

Jan 7th, 2021 - Women's sexual health and wellbeing with cervical or vaginal cancer may be largely affected by complications from external beam radiotherapy (EBRT) and utero-vaginal brachytherapy (BT), of which vaginal stenosis is the main complication. The objec...

Dec 4th, 2020 - Vaginal cancer is a rare disease of the lower genital tract. We present the case of a 54-year-old woman with occult vaginal cancer after hysterectomy for cervical intraepithelial neoplasia (CIN) III. Despite persistently negative cytology and colp...

Nov 9th, 2020 - The role of the prosthodontist in radiation therapy includes fabrication of radiation therapy prosthetic applicators. Brachytherapy is a form of cancer treatment that involves direct insertion of radioactive implants into the tissue. In the case o...

Nov 9th, 2020 - High dose rate (HDR) interstitial brachytherapy (ISBT) boost is integral for definitive radiation treatment of primary vaginal cancer. Technological advances with CT or MRI guidance provide improved precision and ability to treat more extensively ...

Aug 6th, 2015 - Available HPV Vaccine Products Hello, I'm Dr Sandra Fryhofer. Welcome to Medicine Matters. The topic: HPV vaccination, the transition to HPV9, and gender differences in additional cancer protection. HPV—the human papillomavirus—is linked to cancer...

Jan 14th, 2014 - Women treated for high-grade cervical intraepithelial neoplasia (CIN3) have an increasing risk for invasive cancer after the age of 60, particularly if the treatment was recent, according to a Swedish population-based cohort study published online...

Jan 1st, 2011 - RELATED ARTICLE 2 HPV vaccines, 7 questions that you need answered Neal M. Lonky, MD, MPH, and an expert panel The FDA recently approved the quadrivalent formulation of the human papillomavirus (HPV) vaccine (Merck’s Gardasil) for prevention of an.

Dec 22nd, 2010 - WASHINGTON -- The FDA has approved the human papillomavirus vaccine Gardasil for use in males and females ages 9 to 26 to prevent anal cancer. The decision follows a recommendation from the FDA's advisory committee on vaccines, which voted last mo...

Nov 17th, 2010 - WASHINGTON -- An FDA advisory panel has expressed its support for expanding the indication on the quadrivalent human papillomavirus recombinant vaccine Gardasil to prevent anal intraepithelial neoplasia and anal cancer in males and females ages 9 ...